ACRDF vs BGM
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACRDF is a Hold and BGM is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ACRDF’s FA Score shows that 0 FA rating(s) are green whileBGM’s FA Score has 1 green FA rating(s).
- ACRDF’s FA Score: 0 green, 5 red.
- BGM’s FA Score: 1 green, 4 red.
Price Growth
ACRDF (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while BGM (@Pharmaceuticals: Other) price change was -15.90% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.23%. For the same industry, the average monthly price growth was +2.88%, and the average quarterly price growth was -9.56%.
Reported Earning Dates
ACRDF is expected to report earnings on Mar 05, 2025.
Industries' Descriptions
@Pharmaceuticals: Other (+0.23% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
| ACRDF | BGM | ACRDF / BGM | |
| Capitalization | 30.6M | 24.7M | 124% |
| EBITDA | -120.14M | 3.28M | -3,659% |
| Gain YTD | 0.000 | 12.967 | - |
| P/E Ratio | N/A | 15.98 | - |
| Revenue | 236M | 59.2M | 399% |
| Total Cash | 14.3M | 11.9M | 120% |
| Total Debt | 240M | 13M | 1,846% |
| RSI ODDS (%) |
| Stochastic ODDS (%) |
| Momentum ODDS (%) |
| MACD ODDS (%) |
| TrendWeek ODDS (%) |
| TrendMonth ODDS (%) |
| Advances ODDS (%) |
| Declines ODDS (%) |
| BollingerBands ODDS (%) |
| Aroon ODDS (%) |
ACRDF and
Correlation & Price change
A.I.dvisor tells us that ACRDF and ORGO have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ACRDF and ORGO's prices will move in lockstep.
| Ticker / NAME | Correlation To ACRDF | 1D Price Change % | ||
|---|---|---|---|---|
| ACRDF | 100% | N/A | ||
| ORGO - ACRDF | 21% Poorly correlated | +0.30% | ||
| VTRS - ACRDF | 15% Poorly correlated | -0.35% | ||
| CRYM - ACRDF | 13% Poorly correlated | N/A | ||
| INDV - ACRDF | 11% Poorly correlated | -0.09% | ||
| BGM - ACRDF | 11% Poorly correlated | +1.23% | ||
More | ||||
BGM and
Correlation & Price change
A.I.dvisor indicates that over the last year, BGM has been closely correlated with APNHF. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if BGM jumps, then APNHF could also see price increases.
| Ticker / NAME | Correlation To BGM | 1D Price Change % | ||
|---|---|---|---|---|
| BGM | 100% | +1.23% | ||
| APNHF - BGM | 73% Closely correlated | N/A | ||
| MSTH - BGM | 28% Poorly correlated | N/A | ||
| SXTC - BGM | 25% Poorly correlated | +0.10% | ||
| CPIX - BGM | 21% Poorly correlated | -8.66% | ||
| YCBD - BGM | 21% Poorly correlated | -10.38% | ||
More | ||||